IRTC · iRhythm Holdings, Inc. · Webcasts, Transcripts & Audio
$124.42
+0.67 (+0.54%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$4.08B
Shares
32.96M
Volume · Oct 28
258.41K
Avg daily vol (3M)
569.73K
iRhythm Holdings, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for iRhythm Holdings, Inc. (IRTC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-05
iRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-09
iRhythm Holdings, Inc. (IRTC) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
iRhythm Holdings, Inc. (IRTC) Q2 2026 Earnings Call Transcript
Confident tone
Vital Connect acquisition
Innovative Channels / primary care expansion
Revenue growth and commercial momentum
Revenue
$224.17M
▲ 20.1% YoY Diluted EPS
$-0.01
Gross margin
72.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-16
iRhythm Holdings, Inc. (IRTC) June 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
iRhythm Holdings, Inc. (IRTC) June 2, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-13
iRhythm Holdings, Inc. (IRTC) May 13, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-30
iRhythm Holdings, Inc. (IRTC) Q1 2026 Earnings Call Transcript
Confident tone
Sleep diagnostics opportunity
Primary care and upstream patient pathway expansion
Quarterly financial performance and profitability
Revenue
$199.39M
▲ 25.7% YoY Diluted EPS
$-0.43
Gross margin
70.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-19
iRhythm Holdings, Inc. (IRTC) Q4 2025 Earnings Call Transcript
Confident tone
MCT market share opportunity and cybersecurity gateway
Market share and long-term monitoring leadership
Predictive AI and innovative channel partnerships
Revenue
$208.89M*
▲ 27.1% YoY Gross margin
70.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-30
iRhythm Holdings, Inc. (IRTC) Q3 2025 Earnings Call Transcript
Confident tone
Zio MCT and product pipeline
Revenue growth and commercial momentum
Sleep diagnostics expansion
Revenue
$192.88M
▲ 30.7% YoY Diluted EPS
$-0.16
Gross margin
71.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
iRhythm Holdings, Inc. (IRTC) Q2 2025 Earnings Call Transcript
Confident tone
Revenue growth and core business momentum
Zio MCT product and FDA submission
Innovative channel partnerships and Signify Health
Revenue
$186.69M
▲ 26.1% YoY Diluted EPS
$-0.44
Gross margin
71.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
iRhythm Holdings, Inc. (IRTC) Q1 2025 Earnings Call Transcript
Confident tone
Zio AT (Mobile Cardiac Telemetry) Momentum
Primary Care Channel Expansion and Undiagnosed Market
FDA Engagement and Regulatory Progress
Revenue
$158.68M
▲ 20.3% YoY Diluted EPS
$-0.97
Gross margin
68.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
iRhythm Holdings, Inc. (IRTC) Q4 2024 Earnings Call Transcript
Confident tone
Zio Monitor and Zio AT
Tariffs
International Expansion and Zio MCT
Revenue
$164.32M*
▲ 24% YoY Gross margin
70.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-30
iRhythm Holdings, Inc. (IRTC) Q3 2024 Earnings Call Transcript
Positive tone
FDA remediation and quality system overhaul
Zio AT 510(k) clearances
Zio MCT next-generation product delay
Revenue
$147.54M
▲ 18.4% YoY Diluted EPS
$-1.48
Gross margin
68.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
iRhythm Holdings, Inc. (IRTC) Q2 2024 Earnings Call Transcript
Confident tone
Core business growth and revenue performance
Zio MCT product launch
Primary care channel expansion
Revenue
$148.05M
▲ 19.3% YoY Diluted EPS
$-0.65
Gross margin
69.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
iRhythm Holdings, Inc. (IRTC) Q1 2024 Earnings Call Transcript
Confident tone
Revenue growth and 2024 guidance
Zio Monitor rollout and compliance
Primary care channel expansion
Revenue
$131.93M
▲ 18.4% YoY Diluted EPS
$-1.47
Gross margin
66.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
iRhythm Holdings, Inc. (IRTC) Q4 2023 Earnings Call Transcript
Confident tone
Zio AT / MCT business and FDA warning letter
Zio monitor launch and adoption
Primary care channel expansion
Revenue
$132.51M*
▲ 17.7% YoY Gross margin
66.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
iRhythm Holdings, Inc. (IRTC) Q3 2023 Earnings Call Transcript
Revenue
$124.60M
▲ 20% YoY Diluted EPS
$-0.89
Gross margin
66.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
iRhythm Holdings, Inc. (IRTC) Q2 2023 Earnings Call Transcript
Revenue
$124.13M
▲ 21.6% YoY Diluted EPS
$-0.61
Gross margin
69.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
iRhythm Holdings, Inc. (IRTC) Q1 2023 Earnings Call Transcript
Revenue
$111.44M
▲ 20.6% YoY Diluted EPS
$-1.29
Gross margin
67.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
iRhythm Holdings, Inc. (IRTC) Q4 2022 Earnings Call Transcript
Revenue
$112.62M*
▲ 37.7% YoY Gross margin
69.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
iRhythm Holdings, Inc. (IRTC) Q3 2022 Earnings Call Transcript
Revenue
$103.88M
▲ 21.6% YoY Diluted EPS
$-0.71
Gross margin
68.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
iRhythm Holdings, Inc. (IRTC) Q2 2022 Earnings Call Transcript
Revenue
$102.05M
▲ 25.6% YoY Diluted EPS
$-0.80
Gross margin
68.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
iRhythm Holdings, Inc. (IRTC) Q1 2022 Earnings Call Transcript
Revenue
$92.38M
▲ 24.3% YoY Diluted EPS
$-1.71
Gross margin
66.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
iRhythm Holdings, Inc. (IRTC) Q4 2021 Earnings Call Transcript
Revenue
$81.80M*
▲ 3.8% YoY Gross margin
62.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
iRhythm Holdings, Inc. (IRTC) Q3 2021 Earnings Call Transcript
Revenue
$85.43M
▲ 18.7% YoY Diluted EPS
$-0.81
Gross margin
65.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
iRhythm Holdings, Inc. (IRTC) Q2 2021 Earnings Call Transcript
Revenue
$81.28M
▲ 59.8% YoY Diluted EPS
$-0.59
Gross margin
68.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
iRhythm Holdings, Inc. (IRTC) Q1 2021 Earnings Call Transcript
Revenue
$74.31M
▲ 17% YoY Diluted EPS
$-0.95
Gross margin
68.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
iRhythm Holdings, Inc. (IRTC) Q4 2020 Earnings Call Transcript
Revenue
$78.81M
▲ 33.3% YoY Gross margin
74.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
iRhythm Holdings, Inc. (IRTC) Q3 2020 Earnings Call Transcript
Revenue
$71.94M
▲ 31.6% YoY Diluted EPS
$-0.17
Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
iRhythm Holdings, Inc. (IRTC) Q2 2020 Earnings Call Transcript
Revenue
$50.88M
▼ 3% YoY Diluted EPS
$-0.75
Gross margin
69.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-09
iRhythm Holdings, Inc. (IRTC) Q1 2020 Earnings Call Transcript
Revenue
$63.53M
▲ 31.4% YoY Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
iRhythm Holdings, Inc. (IRTC) Q4 2019 Earnings Call
Revenue
$59.10M
▲ 41.5% YoY Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–32 of 32 webcasts
Key facts
CIK
1388658
CUSIP
450056106
13F (30d)
59 filings
54 filers
Visit website
Investor relations